Therapy
Research And Development
Health

Sangamo Therapeutics

$9.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.28 (-2.87%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SGMO and other stocks, options, ETFs, and crypto commission-free!

About

Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. Read More The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.

Employees
302
Headquarters
Richmond, California
Founded
1995
Market Cap
996.68M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.16M
High Today
$9.75
Low Today
$9.25
Open Price
$9.62
Volume
659.90K
52 Week High
$19.25
52 Week Low
$6.26

Collections

Therapy
Research And Development
Health
Biotechnology
Engineering
Technology

News

Yahoo FinanceMay 10

Sangamo Therapeutics Announces Participation In The Bank Of America Merrill Lynch 2019 Health Care Conference

BRISBANE, Calif., May 10, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO) announced today that Sangamo will participate in the Bank of America Merrill Lynch 2019 Health Care Conference being held next week in Las Vegas. A "fireside chat" discussion with Sangamo CEO Sandy Macrae is scheduled for Tuesday, May 14th at 5 p.m. PT. Sangamo Therapeutics, Inc. (PRNewsfoto/Sangamo Therapeutics, Inc.) More The discussion will be webcast live and may be accessed via a link on the Sangamo Therapeutics website ...

552
Yahoo FinanceMay 9

Edited Transcript of SGMO earnings conference call or presentation 8-May-19 9:00pm GMT

Q1 2019 Sangamo Therapeutics Inc Earnings Call RICHMOND May 9, 2019 (Thomson StreetEvents) -- Edited Transcript of Sangamo Therapeutics Inc earnings conference call or presentation Wednesday, May 8, 2019 at 9:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Alexander D. Macrae Sangamo Therapeutics, Inc. - CEO, President & Dire...

36
Yahoo FinanceMay 8

Sangamo Therapeutics Reports Q1 Loss, Lags Revenue Estimates

12

Earnings

-$0.41
-$0.11
$0.18
$0.48
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.